Rivastigmine | Health Canada Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Rivastigmine
Health Canada Patents

PharmaCompass Sponsored Ads

Contact Supplier

Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.

Contact Supplier

pharmacompass-1-m-2025-08-25

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

pharmacompass-2-m-2025-08-25

Rivastigmine

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

39 API Suppliers, 13 USDMF, 8 CEP/COS, 6 JDMF, 6 EU WC, 18 KDMF, 5 NDC API, 16 Listed Suppliers, $ API Reference Price

39 API Suppliers
13 USDMF
8 CEP/COS
6 JDMF
6 EU WC
18 KDMF
5 NDC API
16 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

357 FDF Dossiers, 18 FDA Orange Book, 269 Europe, 7 Canada, 14 Australia, 8 South Africa, 41 Listed Dossiers

357 FDF Dossiers
18 FDA Orange Book
269 Europe
7 Canada
14 Australia
8 South Africa
41 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 DKSH, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Gangwal Chemicals, 1 Sigachi Industries

1 DKSH
1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd
1 Gangwal Chemicals
1 Sigachi Industries

EXCIPIENTS BY APPLICATIONS

2 Emulsifying Agents, 2 Lubricants & Glidants, 1 Fillers, Diluents & Binders, 1 Thickeners and Stabilizers, 1 Direct Compression, 1 API Stability Enhancers, 1 Co-Processed Excipients

2 Emulsifying Agents
2 Lubricants & Glidants
1 Fillers, Diluents & Binders
1 Thickeners and Stabilizers
1 Direct Compression
1 API Stability Enhancers
1 Co-Processed Excipients

DIGITAL CONTENT

11 News #PharmaBuzz

11 News #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 245 Regulatory FDF Prices, 10 Annual Reports

8 US Medicaid Prescriptions
245 Regulatory FDF Prices
10 Annual Reports

MARKET PLACE

8 APIs, 1 FDF Dossiers

8 APIs
1 FDF Dossiers

PATENTS & EXCLUSIVITIES

3 Health Canada Patents

3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 4 Others

3 EDQM
4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 2,015 Xls

Filters

Reset all filters

Filters

FILTER :

filter Company Reset all filters

3 All

01 3Gowlings

filter Patent Reset all filters

3 All

01 32315784

filter Product Reset all filters

3 All

01 1RIVASTIGMINE

02 2Rivastigmine

filter Dosage Reset all filters

3 All

01 1PATCH

02 2Patch

filter Exp Date Reset all filters

3 All

01 32019-01-08

Product Main Page

01

Gowlings

Rivastigmine

Peptide Process CMC

Not Confirmed

Gowlings

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

Rivastigmine

Brand Name : EXELON PATCH 5

Patent Number : 2315784

Filing Date : 1999-01-08

Strength per Unit : 9.0mg / 5cm

Dosage Form : Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

Gowlings

Rivastigmine

Peptide Process CMC

Not Confirmed

Gowlings

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

Rivastigmine

Brand Name : EXELON PATCH 10

Patent Number : 2315784

Filing Date : 1999-01-08

Strength per Unit : 18.0mg / 10cm

Dosage Form : Patch

Human Or VET : Human

Route of Administration : Transdermal

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

Gowlings

Rivastigmine

Peptide Process CMC

Not Confirmed

Gowlings

Canada

Peptide Process CMC

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

Rivastigmine

Brand Name : EXELON PATCH 15

Patent Number : 2315784

Filing Date : 1999-01-08

Strength per Unit : 27.0 mg / 15 cm

Dosage Form : PATCH

Human Or VET : Human

Route of Administration : TRANSDERMAL

Patent Expiration Date : 2019-01-08

Date Granted : 2006-06-27

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!